IHC of PSA is usually performed to achieve a diagnosis of prostate cancer [18, 19], but there is a possibility that the characteristics of the cancer are changed during treatment with chemotherapy or radiation therapy [19, 20]. This evidence concerns the gene KLK3 and prostate cancer.